Хондрогард® 100 мг/мл 2 мл раствор для внутривенного введения

Land: Kirgisistan

Sprog: russisk

Kilde: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Aktiv bestanddel:

Хондроитина сульфат

Tilgængelig fra:

ЗАО "ФармФирма "Сотекс" (ЗАО "ФармФирма "Сотекс")

ATC-kode:

M01AX25

INN (International Name):

Chondroitin sulfate

Dosering:

100 мг/мл 2 мл

Lægemiddelform:

раствор для внутривенного введения

Enheder i pakken:

№10

Recept type:

по рецепту

Fremstillet af:

ЗАО "ФармФирма "Сотекс" (Россия)

Produkt oversigt:

ПЖВЛС: нет

Autorisation dato:

2017-11-20

Produktets egenskaber

Mr.lrrucre
K
Av
r4HC
TpyKrIUq
rro
MEAT4TITTHCKOMy
rrpr4MEHEHr4rO
Jr
CPENCTBA
xoHAPOTAPA@
Topronoe
Ha3BaHVe:
XoH4porap4@
r.
MHH
rrJrr.{
rpyrrflupo
BoqHo
e Ha3B
aHrre
: Xou4porarrana
cy:n
S
ar
JlenapcrneHHaq
Qopua
:
pacrBop
Anq
BHyrprrMbrrrreqHoro
BBeAeHr4s
YTBEPX,IIAIO
rlepnrrfi
3aMecrvreJrb
AnpeKTopa
{euapraueH..Ta.,J-r
fo
o6ecn
eqeH
vs
rr
v.p1u.ugncrcofi
lgqnr{KH
-
200
ur;
-
18,0
u r
-
2,0
ur
Ao
pH
6,0-7,5
Ao
2,0
lrn
Cocrae
Ha
oAHy
aMrryJry
fleilcmeynu4ee
6eu4ecm6o
:
xoHApor.rrrrna
cynr
S
ar
Ha'rprrn
6
C0OX4O
2
Ame
nbHde
6
elue cmB
a.'
6ensr4roerrft
cnnpr
Harpkr
fl,
na
era6z
cynr
S
ur
HATpLrs.
frzApoKcrzA
BoAa
Anr
znrerqufi
-
1 0 0
-
9,0
ur
-
1,0
u r
ao
pH
6,0-7,5
Ao
1,0
un
Onucanue
flpospa.iuufi
6ecqserHtrfi
urv
co
cJrerKa
6eugurosoro
cnrzpra.
xeJrToBaTbrM
oTTeHKOM paCTBOp
C
3anaxoM
@apvrarcoreparreBTrrqecKas
rpy[rra
: Peuapaquu
rxanefi
cr[Mynsrop.
Koa
ATX:
M01AX25
@apuaxonorrrqecKoe
gefi
crnue
(DapnuxoduHurttrKu
BrrcorouoneKynspHr,Ifi
ruyrororvcaxapv1,
eruxrorqafi
Ha
o6ineugbre
npoqeccbr
B rr.{iurr4HoBoM
xpgqe.
Ylreururaer
AefeHeparl4BHble
r,r3MeHeHr4r
B
xpsrrleBoft
rrann
cycraBoB,
ycKopger
Ilpoqeccbr
e€ noccraHoBreHr4s,
crr4Mynr4pyer
cI4HTe3
npOTeorJIrrKaHoB.
flp"
rerreHlln
npeflaparoM
yMeHbrxaerc-f,
6o:resueHuocr
14
ynyquaerc.f,
rroABr.r]KHocrb
lopax{eHHblx
cycraBon.
llpu
JIerreHI4I4
lereHeparr4BHErx
z:uenenrzfi
cycraBoB
c
pa3BI4Tr{eM
BTopur{Horo
cIlHoBlrra,
rloJlox{uremnufi
:S@exr
Moxer
na6nrogarrcr
yxe
qepe3
2-3
p1elenu
nocJle
Harlara
BBeAeHI,It
npenapara: yMeHbrlraercs
6olr
B
cycraBax,
Hcrre3aror
KJrr4HVqecKIze
rlpotBneHl4{
peaKTI{BHofo
cIlHoBHTa, yBenur{r4Baercr
o6:setr
4nzNenzft
B
nopai1egHbrx
cycraBax.
Tepanenrzqecxzft
e$Serr
coxpaH-serc-f,
AJrr4TeJrbHoe
BpeMr
[ocJre
oKoHrraHr]r
Kypca
JIEqEHI4,f,.
@apmaxoxuHemuna
floc:re
BHyrpI'IMbIIrIerrHofo
BBeAeHr.r.f,
xoHrpolrrr.rHa
cynrsar
6srcrpo
pacnperenqerc_f,.
VNe
qepe3
30 lruH rIocJIe
I4HbeKuLII4
ou
o6Hapy)KLrBaercfl.
B
KpoBr4
B 3Har{urelbHbrx
KoHrIeHTparIIrf,x.
MarcuNaa,lbHa-s
KoHIIeHTpar\vs.
(Cmax)
xoHApor,rrr{Ha
cy:rr,$ara
B
[Jra3Me
Aocrrrraercf,
rrepe3